Anlotinib trials for Non-Small-Cell Lung Cancer

All Anlotinib trials · All Non-Small-Cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Anlotinib for Non-Small-Cell Lung Cancer

• Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer
  NCT04322617 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study
  NCT06188650 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
  NCT06352008 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Anlotinib for Non-Small-Cell Lung Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.